Skip to main content
Quest Diagnostics

Updated Trial in Progress: Understanding Treatment Experience of Individuals Receiving Isatuximab Using Both Patient-reported Outcomes and Wearable Data

International Myeloma Sciety 19th Annual Meeting and Exposition

IMW2022

Los Angeles, CA, Aug 25-27, 2022

Oral presentation: Updated trial in progress: understanding treatment experience of individuals receiving isatuximab using both patient-reported outcomes and wearable data

Authors: Manasanch E, Banerjee R, Brassil K, Shah N, Cowan A

Specialties: Oncology

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.